Overview of Dr. Goodspeed
Dr. Kimberly Goodspeed is a pediatrician in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from McGovern Medical School at UTHealth and has been in practice 5 years. She is one of 269 doctors at University of Texas Southwestern Medical Center who specialize in Pediatrics. She has more than 20 publications and over 500 citings.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Fax+1 214-867-5389
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Neurodevelopmental Disabilities, 2014 - 2018
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2012 - 2015
- McGovern Medical School at UTHealthClass of 2012
Certifications & Licensure
- TX State Medical License 2017 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Clinical Trials
- A Natural History Study of Aspartylglucosaminuria Start of enrollment: 2019 Apr 18
Publications & Presentations
PubMed
- 363 citationsCurrent Clinical Applications of In Vivo Gene Therapy with AAVs.Jerry R. Mendell, Samiah Al-Zaidy, Louise R. Rodino-Klapac, Kimberly Goodspeed, Steven J. Gray
Molecular Therapy. 2021-02-03 - 38 citationsCurrent knowledge of SLC6A1-related neurodevelopmental disorders.Kimberly Goodspeed, Eduardo Pérez-Palma, Sumaiya Iqbal, Dominique Cooper, Annalisa Scimemi
Brain Communications. 2020-10-13 - 4 citationsPatterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder.Sanjana Kalvakuntla, MinJae Lee, Wendy K Chung, Scott Demarest, Amber Freed
Frontiers in Neuroscience. 2023-01-01
Journal Articles
- Pitt-Hopkins Syndrome: A Unique Case StudyVeronica Bordes Edgar, Kimberly Goodspeed, Journal of the International Neuropsychological Society
Press Mentions
- Repurposing Approved Drugs as Inhibitors of K v 7.1 and Na v 1.8 to Treat Pitt Hopkins SyndromeJuly 22nd, 2020
- Bringing Everyone to the Table – Findings from the 2018 Phelan-McDermid Syndrome Foundation International ConferenceJune 16th, 2020
- Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)April 23rd, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: